Pierre Coliat
17 Rue Albert Calmette
Strasbourg, 67033, France
Strasbourg, 67033, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
NF-κB signaling drives rapid skeletal muscle atrophy in patients with breast cancer: the cost of fighting cancer with chemotherapy.
Journal: American journal of physiology. Cell physiology
Published: April 16, 2026
Oncology pharmacy practice: Key insights, challenges, and perspectives - A position paper from the French Society for Oncology Pharmacy (SFPO).
Journal: Annales pharmaceutiques francaises
Published: April 17, 2025
Influence of pneumatic transportation on the stability of monoclonal antibodies.
Journal: Scientific reports
Published: June 30, 2023
Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: September 28, 2022
A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 27, 2022
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: January 15, 2022
Optimal Physicochemical Properties of Antibody-Nanoparticle Conjugates for Improved Tumor Targeting.
Optimal Physicochemical Properties of Antibody-Nanoparticle Conjugates for Improved Tumor Targeting.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: December 17, 2021
Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 18, 2021
Protective role of melatonin in breast cancer: what we can learn from women with blindness.
Journal: Cancer causes & control : CCC
Published: April 27, 2021
TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin® and US-Herceptin® in healthy male subjects.
Journal: Pharmacology research & perspectives
Published: March 07, 2021
Last Updated: 09/26/2026